CLINICAL_TRIALS
trial_result
· 2025-08-29
Clinical Trial Update: Study of Anti-Malarials in Incomplete Lupus Erythematosus [Phase 2]
Summary
Phase 2 trial evaluating anti-malarial therapy in incomplete lupus erythematosus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Milton S. Hershey Medical Center | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2025-08-29